Thank You Victoria!

“Not only do I use natural health products, but it’s my job to recommend them to people. I feel my livelihood is being threatened, so I’m glad to contribute to the cause.”

Victoria, your letter is on point. You FEEL your livelihood being threatened, because it IS being threatened – along with your right to health freedom. Thank you for being aware and engaged as both a member of the Canadian public and a natural health product retail employee. We appreciate you standing up and taking action by collecting signatures in favour of the Charter of Health Freedom petition. Your voice and the voice of those in your network have joined over 100,000 other Canadians who believe in freedom of choice in healthcare. As you said, “this is important work” – so thank you for being part of the solution.

Print your own copy of the Charter of Health Freedom petition and start collecting signatures.

January 2020 Charter of Health Freedom Petition Count

Envelopes mailed in. Each one opened with gratitude. Every enclosed petition page reviewed for integrity. The count is on! We anticipate that your involvement during our 2019 postcard campaign could lead us to the single largest petition count since NHPPA began collecting signatures supporting the Charter of Health Freedom in 2008! THAT is not a small thing. We still need a Member of Parliament, whose party sits in power, to be the lead in bringing the petition and the Charter of Health Freedom to the house. But today, we focus on the success of a collective movement that will show solidarity for natural health products in numbers!

Start collecting petition signatures today.

Store and clinic support kits.

MedEffect e-Notice from Health Canada | Uloric Associated with Risk of Higher Fatal Outcomes

On November 3, 2019, Health Canada published a MedEffect Notice advising of a higher risk associated with cardiovascular fatal outcomes, such as heart attacks, strokes, and heart-related deaths, in patients with gout and known cardiovascular disease treated with ULORIC (febuxostat), when compared to those treated with allopurinol

Uloric is used to lower serum uric acid levels in patients with gout who had an inadequate response or intolerance to another drug, allopurinal, or for those determined that allopurinol was inappropriate.


Shelved as a Reminder of Success. What’s Next?

Just shortly after 2019’s election day and the end of the “Do You Want My Vote?” MP postcard campaign we had to press pause on our work. The postcard is now tucked away with a few of our mentors—Shiv Chopra, Helke Ferrie, Jozef Krop and Jeffrey Smith. We are inspired and reminded that if we continue pushback, change can happen. This postcard initiative was one of NHPPA’s most successful actions to date. It had gravity. It was the perfect partnership between manufacturers, retailers, the public and NHPPA.


Thank You Catherine!

“This is Canada, a country that brags about the rights and freedoms of every person. That freedom must include a health care system that supports not only conventional medicine but one that is diverse and includes natural health products and practices.”

Catherine, I do not think we could have said it better ourselves. Thank you for writing us to share your lifeline story through the use of natural health products. In fact, many Canadians have shared similar experiences with us over the years. We cannot express how meaningful it is when we receive letters like this. It recommits us to the work we do. Catherine deserves access to the remedies that are most effective for her. We all do. It is why we challenge the status quo and take steps to preserve our rights. Health freedom matters too much.

Health Outcomes First. Let Bureaucrats Know.

There are at least three more quotes we want to share from Brett Hawes’ podcast interview with Shawn Buckley. They are just too good to miss. The subject of intellectual property rights is one that flows through all areas of government policy development. In the case of chemical drugs, the intellectual property rights a pharmaceutical company owns over their drug product are prioritized over healing potential. Intellectual property laws protect drug companies from others copying their patented formula. This allows them to recoup research costs. The patent period creates a monopoly for each individual new drug. That then secures profitability by eliminating competition and justifying astronomical prices to consumers in the name of scientific innovation.


Thank You to NHP Manufacturers!

Manufacturers catalyze NHPPA’s work—but only a few. Kudos go out to those who have allowed us to take action. Their partnerships are without equal. They were the backbone that drove the success of our “Do You Want My Vote?” MP postcard campaign. The campaign saw over 320,000 postcards shipped across the country. It was possible for NHPPA to reach retailers through their channels. They recognize what they, and all Canadians, have to lose if the Self-Care Framework is fully implemented.